210963-67-0

Upstream product

• 34404-30-3 N-(tert-butoxycarbonyl)-D-glutamic acid 1-benzyl ester 
• 79338-14-0 D-glutamic acid 1-benzyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 918650-29-0 phenylmethyl (2R)-5-(3-{(2S)-2-[(3,3-dimethyl-3-silabutyl)oxycarbonyl]-2-[(phenylmethoxy)carbonylamino]ethyl}phenoxy)-2-[(tert-butoxy)carbonylamino]pentanoate 
• 850742-57-3 (R)-N-tert-butoxycarbonyl-δ-(N4-benzyloxycarbonyl-1-cytosinyl)norvaline benzyl ester 
• 850742-59-5 (R)-N-tert-butoxycarbonyl-δ-(2-amino-6-chloro-9-purinyl)norvaline benzyl ester 
• 850742-77-7 (R)-N-tert-butoxycarbonyl-δ-(N4-benzyloxycarbonyl-1-cytosinyl)norvaline 
• 850742-55-1 (R)-N-tert-butoxycarbonyl-δ-(9-adeninyl)norvaline benzyl ester 
• 850742-53-9 (R)-N-tert-butoxycarbonyl-δ-(1-thyminyl)norvaline benzyl ester 
• 850742-61-9 (R)-δ-(9-guaninyl)norvaline benzyl ester 
• 850742-49-3 (R)-N-tert-butoxycarbonyl-δ-bromo-norvaline benzyl ester 

Relevant academic research and scientific papers

Total Synthesis and Antimicrobial Activity of Chlorocatechelin A

Chlorocatechelin A (1) is a structurally unique microbial siderophore containing two units of 4-chloro-2,3-dihydroxybenzoic acid (CDB) and a characteristic acylguanidine structure. Purification from the microbe culture is not an easy task due to the labil

NOVEL BIOACTIVE SUBSTANCE

PROBLEM TO BE SOLVED: To provide a novel compound useful as an aminopeptidase A inhibitor. SOLUTION: This invention provides a compound represented by formula (I) or salt thereof, and a pharmaceutical composition comprising the same, wherein R1

18F-LABELED PSMA-TARGETED PET IMAGING AGENTS

Compounds of Marlush formula (I) described in the claims are useful in diagnostic methods for detecting and/or identifying cells presenting PSMA. Disclosed are also methods for preparing the compounds. Representative compounds according to the application

BENZIIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS SODIUM CHANNEL MODULATORS

The invention relates to benzimidazole and imidazopyridine derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new Nav1.8 modulators of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7. X and Y are as defined in the description. Nav1.8 modulators are potentially useful in the treatment of a wide range of disorders, particularly pain.

Side chain homologation of alanyl peptide nucleic acids: Pairing selectivity and stacking

Alanyl peptide nucleic acids (alanyl-PNAs) are oligomers based on a regular peptide backbone with alternating configuration of the amino acids. All side chains are modified by covalently linked nucleobases. Alanyl-PNAs form very rigid, well defined, and l